The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis
2 other identifiers
interventional
11
1 country
1
Brief Summary
To test the hypothesis that an exercise session combined with adequate nutritional supplementation improves skeletal muscle protein accretion during a hemodialysis session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedJuly 9, 2009
July 1, 2009
2.1 years
September 13, 2005
July 8, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
improvement in net protein muscle balance
10 hours
Secondary Outcomes (1)
improvement in net whole body protein balance
10 hours
Study Arms (2)
1
ACTIVE COMPARATORnutritional supplement plus resistance exercise
2
ACTIVE COMPARATORnutritional supplement only (resistance exercise will not be performed)
Interventions
2 oral ingestions per study visit of protein supplement containing a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat; 6 study visits over a 12-month period
resistance training on a duel leg press consisting of 3 sets of 8-12 repetitions; the first 5 study visits over a 12-month period
Eligibility Criteria
You may qualify if:
- On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program.
- Adequately dialyzed (Kt/V \> 1.2).
- Age 18-75
You may not qualify if:
- Pregnant women.
- Patients unable to perform exercise
- Severe unstable underlying disease besides commonly associated with ESRD. Cardiac patients that are stable will be included.
- Patients hospitalized within the last month prior to the study.
- Patients with malfunctioning arterial-venous access (recirculation and/or blood flow \< 750 ml/min)
- Patients receiving steroids and/or other immunosuppressive agents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alp Ikizler, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 15, 2005
Study Start
April 1, 2005
Primary Completion
May 1, 2007
Study Completion
May 1, 2007
Last Updated
July 9, 2009
Record last verified: 2009-07